Want to see MAIA full AI Analyst Report?
MAIA Biotechnology, Inc. (MAIA) Income Statement
MAIA Biotechnology, Inc. Income Statement
Last quarter (Q2 2026), MAIA Biotechnology, Inc.'s total revenue was $0.00. In Q2, MAIA Biotechnology, Inc.'s net income was $-7.94M. See MAIA Biotechnology, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 24.27M | $ 16.96M | $ 20.18M | $ 16.18M | $ 7.79M | |
| Depreciation and Amortization | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| $ -22.40M | $ -23.25M | $ -19.77M | $ -15.76M | $ -11.75M | |
| $ -24.27M | $ -16.96M | $ -20.18M | $ -16.18M | $ -7.79M | |
| $ 1.87M | $ -6.30M | $ 409.48K | $ 406.92K | $ -4.79M | |
| $ -22.40M | $ -23.25M | $ -19.77M | $ -15.77M | $ -12.58M | |
| $ -22.40M | $ -23.25M | $ -19.77M | $ -15.77M | $ -12.50M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.70 | $ -1.05 | $ -1.49 | $ -1.70 | $ -1.18 |
| Diluted EPS | $ -0.70 | $ -1.05 | $ -1.49 | $ -1.70 | $ -1.18 |
| Weighted Average Shares Outstanding | 32.12M | 22.20M | 13.26M | 9.28M | 10.64M |
| Weighted Average Shares Outstanding (Diluted) | 32.12M | 22.20M | 13.26M | 9.28M | 10.64M |
Currency in USD
